Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Benecol

This article was originally published in The Tan Sheet

Executive Summary

California Secretary of Food & Agriculture to decide by Jan. 20 whether to allow sales of Benecol-containing yogurt. State regulators originally were slated to rule Dec. 19 on a petition from dairy products manufacturer Super Store Industries filed on behalf of McNeil Consumer Healthcare (1"The Tan Sheet" Nov. 22, 1999, In Brief). Reportedly, the state balked at SSI's proposed temporary standard for a cultured dairy product "with a functional dietary ingredient," insisting instead on a nomenclature change to "plant stanol esters"

You may also be interested in...



Benecol

Permission to sell a flavored yogurt-type product containing plant stanol esters in California sought by dairy products manufacturer Super Store Industries, on behalf of Benecol marketer McNeil Consumer Healthcare. A hearing on SSI's petition with the California Department of Food & Agriculture was held Nov. 9, and the department gave McNeil 10 days to submit additional information. State regulators have until Dec. 19 to grant or deny the petition; if they take no action, the product may be sold in the state for one year under a proposed temporary standard drafted "to accommodate other functional dietary food ingredients and their related health benefit statements that may be approved...for other manufacturers or distributors." SSI has been making sample batches of the product for McNeil; proposed labeling says the cultured dairy item "helps promote healthy cholesterol levels"

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel